Radiation Oncology-Ozarks Inc Springfield, MO - 65807

Radiation Oncology-Ozarks Inc is categorized under Doctors in Springfield, MO .

Radiation Oncology-Ozarks Inc was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Jeff Robinson, Director at the company’s single location by writing to 3850 South National Avenue # 100, Springfield, Missouri MO 65807 or by phoning (417) 269-6115. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Radiation Oncology-Ozarks Inc
Contact Person: Jeff Robinson, Director
Address: 3850 South National Avenue # 100, Springfield, Missouri 65807
Phone Number: (417) 269-6115
Website Address: coxhealth.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Radiation Oncology-Ozarks Inc was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Jeff Robinson, Director for inquiries that concern Radiation Oncology-Ozarks Inc by calling the company number (417) 269-6115, as your correspondence is most welcome. Additionally, the physical location of the single location of Radiation Oncology-Ozarks Inc can be found at the coordinates 37.14476,-93.27788 as well as the street address 3850 South National Avenue # 100 in Springfield, Missouri 65807.

For its online presence, you may visit Radiation Oncology-Ozarks Inc’s website at coxhealth.com and engage with its social media outlets through on Twitter and on Facebook.